載入...
Tyrosine kinase inhibitor–induced platelet dysfunction in patients with chronic myeloid leukemia
Dasatinib is associated with increased risk of bleeding among patients with chronic myeloid leukemia, even in the absence of thrombocytopenia, suggesting the presence of a hemostatic defect. We tested platelet aggregation in 91 patients with chronic myeloid leukemia in chronic phase either off-thera...
Na minha lista:
| Main Authors: | , , , |
|---|---|
| 格式: | Artigo |
| 語言: | Inglês |
| 出版: |
American Society of Hematology
2009
|
| 主題: | |
| 在線閱讀: | https://ncbi.nlm.nih.gov/pmc/articles/PMC3952950/ https://ncbi.nlm.nih.gov/pubmed/19414863 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1182/blood-2008-09-180604 |
| 標簽: |
添加標簽
沒有標簽, 成為第一個標記此記錄!
|